ATE201995T1 - METHOD FOR PREVENTION AND TREATMENT OF BOvine MASTITIS - Google Patents

METHOD FOR PREVENTION AND TREATMENT OF BOvine MASTITIS

Info

Publication number
ATE201995T1
ATE201995T1 AT94925425T AT94925425T ATE201995T1 AT E201995 T1 ATE201995 T1 AT E201995T1 AT 94925425 T AT94925425 T AT 94925425T AT 94925425 T AT94925425 T AT 94925425T AT E201995 T1 ATE201995 T1 AT E201995T1
Authority
AT
Austria
Prior art keywords
pct
infection
gallidermin
epidermin
sec
Prior art date
Application number
AT94925425T
Other languages
German (de)
Inventor
John Edmondson Peel
Bruno Suri
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE201995T1 publication Critical patent/ATE201995T1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Abstract

PCT No. PCT/EP94/02567 Sec. 371 Date Feb. 16, 1996 Sec. 102(e) Date Feb. 16, 1996 PCT Filed Aug. 3, 1994 PCT Pub. No. WO95/05844 PCT Pub. Date Mar. 2, 1995A method for treating or preventing mastitis in cows is disclosed. The method contemplates the intramammary injection or dipping the teat with Gallidermin and/or Epidermin or one of their pharmaceutically acceptable acid salts. Gallidermin and/or Epidermin or one of their pharmaceutically acceptable acid salts can be administered prior to infection to effectively suppress the rate, severity, and duration of subsequent bacterial infection, or can be administered subsequent to infection to effectively treat mastitis.
AT94925425T 1993-08-20 1994-08-03 METHOD FOR PREVENTION AND TREATMENT OF BOvine MASTITIS ATE201995T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93810588 1993-08-20
PCT/EP1994/002567 WO1995005844A1 (en) 1993-08-20 1994-08-03 Method for the prevention and treatment of bovine mastitis

Publications (1)

Publication Number Publication Date
ATE201995T1 true ATE201995T1 (en) 2001-06-15

Family

ID=8215016

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94925425T ATE201995T1 (en) 1993-08-20 1994-08-03 METHOD FOR PREVENTION AND TREATMENT OF BOvine MASTITIS

Country Status (13)

Country Link
US (1) US5710124A (en)
EP (1) EP0789581B1 (en)
JP (1) JP3670280B2 (en)
AT (1) ATE201995T1 (en)
AU (1) AU689494B2 (en)
CA (1) CA2169847C (en)
DE (1) DE69427492T2 (en)
DK (1) DK0789581T3 (en)
ES (1) ES2157985T3 (en)
GR (1) GR3036573T3 (en)
NZ (1) NZ271650A (en)
PT (1) PT789581E (en)
WO (1) WO1995005844A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT934075E (en) 1996-06-20 2002-08-30 Novartis Ag METHOD FOR THE PREVENTION AND TREATMENT OF MASTITIS
US6406907B1 (en) 1999-02-26 2002-06-18 Iowa State University Research Foundation Bovine tumor necrosis factor receptor-1 and methods of use
EP1750740A4 (en) * 2004-05-06 2009-06-10 Molichem Medicines Inc Treatment of membrane-associated diseases and disorders using lantibiotic containing compositions
CN100368016C (en) * 2005-04-01 2008-02-13 北京大北农农业科技研究院 Infusion liquid for treating cow mastitis and preparation method thereof
US20100009405A1 (en) * 2005-06-29 2010-01-14 Wolfgang Minas Biosynthetic process for the preparation of gallidermin
JP5619352B2 (en) * 2005-07-28 2014-11-05 バイオシネクサス インコーポレーティッド Compositions and methods for treating bacteria
WO2007044745A1 (en) * 2005-10-11 2007-04-19 Biosynexus Incorporated Lantibiotic and mupirocin compositions for treating bacterial infections
EP2810695A1 (en) * 2013-06-06 2014-12-10 Ceva Sante Animale Compositions and Method for controlling infections in non-human mammals using acute phase proteins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583987D1 (en) * 1984-11-06 1991-10-10 Thomae Gmbh Dr K ANTIBIOTIC POLYPEPTIDE, METHOD FOR THE PRODUCTION AND USE THEREOF.
GB8811760D0 (en) * 1988-05-18 1988-06-22 Thomae Gmbh Dr K Antibiotic
US5304540A (en) * 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
US5334582A (en) * 1988-06-22 1994-08-02 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
AU623864B2 (en) * 1988-08-29 1992-05-28 Applied Microbiology, Inc Method of treating mastitis and other staphylococcal infections
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
DE3938140A1 (en) * 1989-11-16 1991-08-08 Beiersdorf Ag DESODRATING COSMETIC AGENTS
IL104364A (en) * 1992-01-17 1997-09-30 Applied Microbiology Pharmaceutical compositions containing bacteriocins

Also Published As

Publication number Publication date
CA2169847C (en) 2006-02-14
CA2169847A1 (en) 1995-03-02
NZ271650A (en) 1997-11-24
AU689494B2 (en) 1998-04-02
AU7534694A (en) 1995-03-21
JPH09502171A (en) 1997-03-04
GR3036573T3 (en) 2001-12-31
DK0789581T3 (en) 2001-09-17
DE69427492D1 (en) 2001-07-19
PT789581E (en) 2001-11-30
ES2157985T3 (en) 2001-09-01
JP3670280B2 (en) 2005-07-13
DE69427492T2 (en) 2002-04-18
US5710124A (en) 1998-01-20
WO1995005844A1 (en) 1995-03-02
EP0789581A1 (en) 1997-08-20
EP0789581B1 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
PT934075E (en) METHOD FOR THE PREVENTION AND TREATMENT OF MASTITIS
DE69533593D1 (en) PREPARATIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDER CONTAINING ARABINOGALACTAN AND POLYPHENOLS OF LARIX.
DE69430823D1 (en) METHOD FOR TREATING GRAM-NEGATIVE BACTERIA INFECTION BY ADMINISTERING BACTERIA-KILLING / PLEASUREABILITY (BPI) PROTEIN PRODUCT AND ANTIBIOTIC
ATE109624T1 (en) BACTERIOCINE-CONTAINING COMPOSITIONS FOR USE AS IMPROVED BROAD-SPECTRUM BACTERICIDES AND METHODS OF PREVENTING AND TREATMENT OF MICROBIAL INFECTIONS.
MY113059A (en) Controlled-release dosage forms of azithromycin
ATE201995T1 (en) METHOD FOR PREVENTION AND TREATMENT OF BOvine MASTITIS
DK0497956T3 (en) Controlled release preparations
ATE282406T1 (en) MEDICINAL PRODUCTS AND METHODS FOR THE TREATMENT OF INTRACELLULAR INFECTIONS
ATE201598T1 (en) USE OF MOXONIDINE TO TREAT NEUROPATHIC PAIN
DE69005062T2 (en) Fatty acids for the treatment and prevention of skin damage through radiotherapy.
DE69623316T2 (en) CTLA-8 IN COMBINATION WITH G-CSF OR WITH G-CSF AND IL-6, AND USE OF CTLA-8 FOR TREATING INFECTION
ATE167628T1 (en) METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH DEFECTIVE IMMUNE FUNCTION
ATE279939T1 (en) PHYTASE TO PREVENT OR TREAT MASTITIS
DE60222298D1 (en) METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS WITH GEMIFLOXACIN OR ON ITS SALT AND A BETA LACTAM ANTIBIOTICUM
ATE236633T1 (en) TOPICAL USE OF LOPERAMIDE TO TREAT MICROBIAL INFECTIONS
GB9201013D0 (en) Vaccines
DE60228324D1 (en) METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS WITH GEMIFLOXACIN OR ON ITS SALT AND AN ANTIBACTERIAL CARBAPENEM AGENT
Evrard Antibioprophylaxie des fractures ouvertes
ATE490780T1 (en) HUMAN GROWTH HORMONE FOR THE TREATMENT OF ANOREXIA NERVOSA
Evrard Antibiotic prophylaxis in open fractures
胡宝生 et al. CLINICAL OBSERVATION ON AURICULAR POINT TREATMENT FOR 144 CASES OF BILIARY COLIC
MY104932A (en) Immunomodulatory azaspiranes

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner